Current data has a 15-minute delay. Please Sign Up /
Sign In to get real-time quotes.
stocks
/
NASDAQ-TCRX
/
T
TScan Therapeutics
TCRX
TCRXTScan TherapeuticsNASDAQ
Add to watchlist
169.03
0.00(0.00 %)
At close :
Jan 03, 16:00 ET
--
Post market
20:00 ET
T
TScan Therapeutics
TCRX
(TCRX)
169.03
--(0.00 %)
Summary
Options
Financials
News
Filings
Profile
TCRX Chart
See on advanced chart >
...
All
...
D
...
W
...
M
...
5m
...
Volume932.67k
Turnover157.90M
P/E(TTM)19.28
Turnover %0.63%
P/E(Static)18.37
Market Cap34.20B
P/B8.13
Shares202.35M
52 Week Range
166.69
211.92
Day Range
167.95
170.40
About
TScan Therapeutics, Inc. was incorporated in Delaware on April 17, 2018. The company is a preclinical-stage biopharmaceutical company focused on developing a robust pipeline of T cell receptor-engineered T cell, or TCR-T, therapies for the treatment of...
Read More
Highlight
A preclinical-stage biopharmaceutical company that developing T cell receptor engineered T cell therapies for the treatment of cancer